| Educational Session |
09:00~10:10 |
| 1. Innovative treatment in medical oncology |
Room A |
| 1) Innovative treatment in lung cancer |
| Byoung Chul Cho (Yonsei University College of Medicine) |
| 2) Innovative treatment in stomach cancer |
| Do-Youn Oh (Seoul National University College of Medicine ) |
| 3) Innovative treatment in melanoma |
| Eun Joo Kang (Korea University College of Medicine) |
| 2. Role of radiation therapy in lymphoma: When and how? |
Room B |
| 1) RT in indolent non-Hodgkins lymphoma, NK T-cell lymphoma, Hodgkins lymphoma |
| Chang-Ok Suh (Yonsei University College of Medicine) |
| 2) RT in aggressive and highly aggressive non-Hodgkins lymphoma |
| Yong Chan Ahn (Sungkyunkwan University School of Medicine) |
| 3. Cancer surgery: Whats your opinion for tailored approach? |
Room C |
| 1) Stomach cancer |
| Hoon Hur (Ajou University School of Medicine) |
| 2) Colorectal cancer |
| In Kyu Lee (The Catholic University of Korea College of Medicine) |
| 3) Breast cancer |
| Sang Uk Woo (Korea University College of Medicine) |
|
| Plenary Lecture 3 |
10:30~11:10, Room A ~ C |
| Role of scientists and doctors in early clinical trial of JX594 anti-tumor virus |
| Tae-Ho Hwang, DDS, Ph.D. (Pusan National University) |
|
| Plenary Lecture 4 |
11:10~12:00, Room A ~ C |
| Adult Survivors of Sarcoma |
| Laurence H. Baker, DO (University of Michigan Medical School, USA) |
|
| Symposium 5 |
13:50~15:30, Room A |
| Recent issues in early phase clinical trial |
| 1) Early phase clinical trial: Overview |
| Joon Oh Park (Sungkyunkwan University School of Medicine) |
| 2) Recent issues in phase II Clinical trials |
| Sin-Ho Jung (Samsung Medical Center) |
| 3) Early phase clinical trial design in the era of targeted agents |
| Byung-Ho Nam (National Cancer Center) |
| 4) Biomarker exploration in early phase clinical trial |
| Seock-Ah Im (Seoul National University College of Medicine) |
|
| Symposium 6 |
13:50~15:30, Room C |
| Circulating tumor DNA |
| 1) Monitoring EGFR T790M with plasma DNA in lung cancer patients treated with EGFR tyrosine kinase inhibitor in prospective observational study |
| Naoko Sueoka-Aragane (Saga University, Japan) |
| 2) Extracellular vesicles and miRNA as emerging cancer biomarker for liquid biopsy |
| Yusuke Yoshioka (National Cancer Center Research Institute, Japan) |
| 3) Extracelular vesicles and circulating extracellular nucleic acids |
| Yong Song Gho (POSTECH) |
|
| Symposium 7 |
13:50~15:30, Room D |
| Joint Symposium (Korean Cancer Association & Korean Society of Gynecologic Oncology) |
| I: Clinical new paradigm in gynecologic cancer |
|
1) Recent advances in management of recurrent and metastatic cervical cancer: a focus on target therapies |
| Jong-Min Lee (Kyung Hee University School of Medicine) |
|
2) Updates on recent landmark clinical trials in ovarian cancer |
| Byoung-Gie Kim (Sungkyunkwan University School of Medicine) |
|
3) Molecular predictors of response and outcomes in gynecologic cancer |
| Yong Man Kim (University of Ulsan College of Medicine) |
|
| II: Understanding translational research for gynecologic cancer |
|
1) Advances in stem cell research in gynecologic cancer |
| Chi-Heum Cho (Keimyung University School of Medicine) |
|
2) Molecular classification of gynecologic cancers: clinical implication of TCGA for ovarian and endometrial cancers |
| Jae-Weon Kim (Seoul National University College of Medicine) |
|
3) Identifying novel therapeutic molecular targets in gynecologic cancer |
| Jae-Hoon Kim (Yonsei University College of Medicine) |
|
| Symposium 8 |
15:50~17:30, Room A |
| Assessment for quality of cancer treatment |
|
1) Quality measurement of cancer care in HIRA |
| Chang-Hak Sohn (Health Insurance Review & Assessment Service) |
|
2) Quality of care for lung cancer |
| Ki Hyeong Lee (Chungbuk National University College of Medicine) |
|
3) Evaluation of clinical practice in gastric cancer |
| Keun Won Ryu (National Cancer Center) |
|
4) The outcomes of transarterial infusion of epirubicin and cisplatin combined with systemic infusion of 5-fluorouracil for unresectable hepatocellular carcinoma |
| Seung Kew Yoon (The Catholic University of Korea College of Medicine) |
|
| Symposium 9 |
15:50~17:30, Room B |
| Patient driven xenograft |
|
1) Patient derived xenographs : The Jackson Laboratory experience |
| Charles Lee (The Jackson Laboratory for Genomic Medicine, USA) |
|
2) Development and characterization of patient driven xenograft tumor model generated from primary cultured cells |
| Se Jin Jang (University of Ulsan College of Medicine) |
|
3) Experimental and practical approaches to the establishment of patient-derived tumor xenograft model |
| Jeong-Seok Nam (Gachon University School of Medicine) |
|
4) PDX model in breast cancer |
| Hyeong-Gon Moon (Seoul National University College of Medicine) |
|
| Symposium 10 |
15:50~17:30, Room C |
| Joint Symposium (Korean Cancer Association & Korean Association of Thyroid and Endocrine Surgeons) |
| Controversies in the treatment of thyroid cancer |
|
1) Controversies on microcarcinoma |
Young Don Lee (Gachon University School of Medicine)
Jae Hoon Chung (Sungkyunkwan University School of Medicine) |
|
2) Controversies on RAI treatment |
Jeong Soo Kim (The Catholic University of Korea College of Medicine)
June-Key Chung (Seoul National University College of Medicine) |
|
3) Controversies on refractory thyroid cancer |
Hang-Seok Chang (Yonsei University College of Medicine)
The role of external beam radiation and targeted therapy
Young Joo Park (Seoul National University College of Medicine) |
|
| International Session |
13:50~15:30, Room B |
| Clinical research ??/STRONG> |
|
| Clinical research ??/STRONG> |
|
|
| Oral Presentation |
13:50~17:30, Room E
15:50~17:30, Room D |
|
| Luncheon Symposium 2 |
12:00~13:00, Room A ~ C |
|
The past, present and future for colorectal cancer |
| Yong Sang Hong (University of Ulsan College of Medicine) |
|
| General Assembly |
13:00~13:30, Room A ~ C |
|
| Poster |
09:00~17:00, Room F |